CA
NZ
UK
AU
IND
US
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed a joint Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of ordinary shares of Range Capital Acquisition Corp as of September 30, 2026.
GS Finance Corp. filed a Free Writing Prospectus on November 9, 2026, disclosing terms for Market Linked Securities that are autocallable with a fixed percentage buffered downside, linked to the EURO STOXX 50 Index and due November 26, 2029.
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed a joint Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of approximately 5.9% of Tandem Diabetes Care, Inc. common stock as of September 30, 2026.
First Advantage Corporation filed a free writing prospectus on November 9, 2026, announcing that Silver Lake Group, L.L.C. and its affiliates intend to sell 15,000,000 shares of First Advantage common stock in an underwritten secondary offering.
McDonald's Corporation filed a free writing prospectus on November 9, 2026, disclosing the pricing terms of two tranches of SEC-registered senior unsecured fixed-rate medium-term notes totaling USD 1,200,000,000, with settlement expected on November 17, 2026.
Novartis Capital Corporation filed a free writing prospectus on November 9, 2026, disclosing pricing terms for a four-tranche U.S. dollar-denominated notes offering totaling $5,250,000,000, fully and unconditionally guaranteed by Novartis AG.
JATT II Acquisition Corp. filed a definitive proxy statement and prospectus on November 9, 2026, asking shareholders to approve a business combination with Talawar Tx Inc. under a Business Combination Agreement dated June 29, 2026.
Reviva Pharmaceuticals Holdings, Inc. filed a definitive proxy statement on November 9, 2026, calling stockholders to vote on five proposals at an annual meeting scheduled for December 18, 2026, including a potential reverse stock split at a ratio ranging from 1:2 to 1:100.
NeoVolta, Inc. filed a Definitive Proxy Statement on November 9, 2026, notifying stockholders of a 2026 Annual Meeting to be held December 22, 2026, at the company's offices in Poway, California, to vote on director elections, auditor ratification, a new stock plan, and an …
Fly-E Group, Inc. filed Definitive Additional Materials (DEFA14A) on November 9, 2026, supplementing its October 29, 2026 proxy statement to postpone the Special Meeting of Stockholders from November 13 to November 27, 2026, and to clarify and expand disclosure around a proposed securities offering.
Please wait processing your request...